Heding A - Search Results

1

Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

Holst B, Brandt E, Bach A, Heding A, Schwartz TW. Holst B, et al. Among authors: heding a. Mol Endocrinol. 2005 Sep;19(9):2400-11. doi: 10.1210/me.2005-0059. Epub 2005 May 19. Mol Endocrinol. 2005. PMID: 15905359

2

Novel method for the study of receptor Ca2+ signalling exemplified by the NK1 receptor.

Heding A, Elling CE, Schwartz TW. Heding A, et al. J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):241-52. doi: 10.1081/rrs-120014599. J Recept Signal Transduct Res. 2002. PMID: 12503619

3

Characterization of G-protein coupled receptor kinase interaction with the neurokinin-1 receptor using bioluminescence resonance energy transfer.

Jorgensen R, Holliday ND, Hansen JL, Vrecl M, Heding A, Schwartz TW, Elling CE. Jorgensen R, et al. Among authors: heding a. Mol Pharmacol. 2008 Feb;73(2):349-58. doi: 10.1124/mol.107.038877. Epub 2007 Nov 6. Mol Pharmacol. 2008. PMID: 17986524

4

Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2.

Svendsen AM, Vrecl M, Ellis TM, Heding A, Kristensen JB, Wade JD, Bathgate RA, De Meyts P, Nøhr J. Svendsen AM, et al. Among authors: heding a. Endocrinology. 2008 Mar;149(3):1113-20. doi: 10.1210/en.2007-0412. Epub 2007 Dec 6. Endocrinology. 2008. PMID: 18063691

5

Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1.

Svendsen AM, Zalesko A, Kønig J, Vrecl M, Heding A, Kristensen JB, Wade JD, Bathgate RA, De Meyts P, Nøhr J. Svendsen AM, et al. Among authors: heding a. Mol Cell Endocrinol. 2008 Dec 16;296(1-2):10-7. doi: 10.1016/j.mce.2008.07.014. Epub 2008 Aug 3. Mol Cell Endocrinol. 2008. PMID: 18723073

6

Dimerization and negative cooperativity in the relaxin family peptide receptors.

Svendsen AM, Vrecl M, Knudsen L, Heding A, Wade JD, Bathgate RA, De Meyts P, Nøhr J. Svendsen AM, et al. Among authors: heding a. Ann N Y Acad Sci. 2009 Apr;1160:54-9. doi: 10.1111/j.1749-6632.2009.03835.x. Ann N Y Acad Sci. 2009. PMID: 19416159

7

Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor activation.

Jorgensen R, Norklit Roed S, Heding A, Elling CE. Jorgensen R, et al. Among authors: heding a. Pharmacology. 2011;88(3-4):174-81. doi: 10.1159/000330742. Epub 2011 Sep 23. Pharmacology. 2011. PMID: 21952200

8

Bioluminescence resonance energy transfer as a screening assay: Focus on partial and inverse agonism.

Elster L, Elling C, Heding A. Elster L, et al. Among authors: heding a. J Biomol Screen. 2007 Feb;12(1):41-9. doi: 10.1177/1087057106295895. Epub 2006 Nov 17. J Biomol Screen. 2007. PMID: 17114329

9

Development of a BRET2 screening assay using beta-arrestin 2 mutants.

Vrecl M, Jorgensen R, Pogacnik A, Heding A. Vrecl M, et al. Among authors: heding a. J Biomol Screen. 2004 Jun;9(4):322-33. doi: 10.1177/1087057104263212. J Biomol Screen. 2004. PMID: 15191649

10

Opsin oligomerization in a heterologous cell system.

Vrecl M, Drinovec L, Elling C, Heding A. Vrecl M, et al. Among authors: heding a. J Recept Signal Transduct Res. 2006;26(5-6):505-26. doi: 10.1080/10799890600932253. J Recept Signal Transduct Res. 2006. PMID: 17118796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters